Strategic Portfolio Rebalancing and Capital Return Plan
Cannae has sold approximately $1.1 billion of public company stakes since February 2024, significantly reducing its public holdings from 63% to 22% of assets.
The company expects to receive around $630 million from the sale of Dun & Bradstreet, which will be used for share repurchases, debt repayment, and dividends.
Cannae has repurchased 7.6 million shares, or about 12% of outstanding shares, at an average price of $19.71, aiming to close the NAV discount.
The company increased its quarterly dividend by 25% to $0.15 per share, reflecting a commitment to returning capital to shareholders.
Since February 2024, Cannae has returned approximately $414 million through buybacks and dividends, demonstrating a strategic focus on capital deployment.
ARMOUR Capital Management waived $1.65 million of management fees in Q2, offsetting operating expenses.
ARMOUR raised approximately $104.6 million of capital by issuing approximately 6.3 million shares of common stock through an at-the-market offering program during Q2.
ARMOUR's Q2 GAAP net loss related to common stockholders was $78.6 million or $0.94 per common share.
Distributable earnings available to common stockholders was $64.9 million or $0.77 per common share.
Monthly common stock dividends were $0.24 per share, totaling $0.72 for the quarter.
Net interest income was $33.1 million.
Outstanding common shares total 91.5 million.
Quarter ending book value was $16.90 per common share; estimated book value as of July 21 was $16.81 per common share.
Since June 30, ARMOUR raised approximately $58.8 million of capital by issuing approximately 3.5 million shares of common stock through an at-the-market offering program.
Ares Commercial Real Estate reported a GAAP net loss of approximately $11 million or $0.20 per diluted common share for Q2 2025.
Distributable earnings for Q2 2025 were a net loss of approximately $28 million or $0.51 per diluted common share, including a $33 million realized loss related to the exit of a Massachusetts office life sciences loan.
Excluding the realized loss, distributable earnings were approximately $5 million or $0.09 per diluted common share.
Net debt-to-equity ratio, excluding CECL, was stable at 1.2x quarter-over-quarter and down from 1.9x year-over-year.
Outstanding borrowings decreased 6% quarter-over-quarter and 39% year-over-year to $889 million.
The Board declared a regular cash dividend of $0.15 per common share for Q3 2025, with an annualized dividend yield above 13% based on the stock price as of July 31, 2025.
The CECL reserve declined by approximately $20 million to $119 million, representing about 9% of the total outstanding principal balance of loans held for investment.
The company collected $30 million in repayments during Q2 2025, nearly three times the amount collected in the first half of 2024, strengthening liquidity and the balance sheet.
Unfunded commitments were reduced by 50% quarter-over-quarter and 58% year-over-year to $37 million.
Book value increased to $6.7 billion or $12.71 per share, up from $12.39 in the prior quarter.
Dividend yield remains strong at 8.9%, paying out $0.25 per share.
Genesis Capital achieved a record quarter with origination north of $4 billion, more than doubling since acquisition in 2022.
Newrez's servicing portfolio grew to $864 billion with a typical ROE around 20%.
Return on equity (ROE) for the entire company was 17%, with earnings available for distribution at $291.1 million or $0.54 per diluted share, representing an 18% ROE.
Rithm Capital reported GAAP net income of $283.9 million or $0.53 per diluted share for Q2 2025.
Sculptor's asset management business saw $3.5 billion of AUM growth since acquisition, with strong fundraising and performance.
The company ended the quarter with a record $2.1 billion in cash and liquidity.
Adjusted book value per share increased 14% year-over-year to $144.57, excluding unrealized investment gains and losses.
All three segments showed strong net earned premiums and excellent profitability: Business Insurance combined ratio improved to 88.3%, Bond and Specialty to 87.8%, and Personal Insurance to 79.3%.
Capital returned to shareholders totaled $809 million, including $557 million in share repurchases and $252 million in dividends.
Net earned premiums grew 7% to $10.9 billion with an underlying combined ratio improving 3 points to 84.7%.
Net investment income after tax was $774 million, a 6% increase from prior year, driven by a growing fixed income portfolio with total invested assets surpassing $100 billion.
Operating cash flow was $2.3 billion for the quarter, marking the 21st consecutive quarter with over $1 billion in operating cash flow, totaling over $40 billion in that period.
The Travelers Companies, Inc. reported exceptional Q2 2025 results with core income of $1.5 billion or $6.51 per diluted share and a core return on equity of 18.8% for the quarter, 17.1% on a trailing twelve-month basis.